Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Could new COVID variants undermine vaccines? Labs scramble to find out

Access options

Rent or buy this article

Get just this article for as long as you need it


Prices may be subject to local taxes which are calculated during checkout

Nature 589, 177-178 (2021)


Updates & Corrections

  • Update 08 January 2021: This story has been updated with findings from a preprint that suggests the Pfizer–BioNtech vaccine is effective against a mutated form of the SARS-CoV-2 virus.


  1. Xie, X. et al. Preprint at bioRxiv (2021).

  2. Tegally, H. et al. Preprint at medRxiv (2020).

  3. Davies, N. G. et al. Preprint at medRxiv (2020).

  4. Plante, J. A. et al. Nature (2020).

    Article  Google Scholar 

  5. Andreano, E. et al. Preprint at bioRxiv (2020).

  6. Greaney, A. J. et al. Preprint at bioRxiv (2021).

Download references


Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing


Quick links